Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

General Anesthesia: early-phase trial registry

2 of 5 indexed General Anesthesia trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · 2 currently recruiting · #3,391 of 28,707 conditions by registered trial count

General Anesthesia: 5 US clinical trials tracked, 2 recruiting.

General Anesthesia is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Haisco-USA Pharmaceuticals, running 1 of these trials.

Enrollment posture brief

Registry condition general-anesthesia

OPEN 2 | RECR 40% | LATE 1 | EARLY 2 | RANK #3391 | SPON 1

Nearest open-share peer: Achondroplasia (40% recruiting · 10 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%General Anesthesia (this)40%
Open-enrollment share among volume-matched conditions near General Anesthesia

General Anesthesia lists 2 open slots (40% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for General Anesthesia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. General Anesthesia is recruiting below its size-band peers.

    2 of 5 indexed trials (40%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates General Anesthesia research.

    Haisco-USA Pharmaceuticals accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical General Anesthesia enrolment sits around 490 participants.

    Median target enrolment is 490 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.

  4. General Anesthesia splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 41

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 4 1

Named interventions

Most-linked intervention names on General Anesthesia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Propofol Anesthesia Drug
1 trials
HSK3486 Drug
1 trials
Propofol Drug
1 trials
Neostigmine Drug
1 trials
Sugammadex Drug
1 trials
Cisatracurium Drug
1 trials
Rocuronium Drug
1 trials
Placebo Drug
1 trials

US sites by state

Facility locations filed on General Anesthesia trials. A trial with sites in several states counts in each.

Illinois 2 trials
California 2 trials
Utah 1 trials
Texas 1 trials
New York 1 trials
New Mexico 1 trials
New Hampshire 1 trials
Missouri 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this General Anesthesia page

5 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This General Anesthesia condition card totals 5 registered trials; most-linked intervention Propofol Anesthesia; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.